ALS Limited (ALQ.AX)
- Previous Close
13.30 - Open
13.25 - Bid 12.99 x 224800
- Ask 13.14 x 228000
- Day's Range
12.81 - 13.25 - 52 Week Range
10.52 - 13.81 - Volume
823,851 - Avg. Volume
812,186 - Market Cap (intraday)
6.314B - Beta (5Y Monthly) 1.16
- PE Ratio (TTM)
24.15 - EPS (TTM)
0.54 - Earnings Date May 21, 2024
- Forward Dividend & Yield 0.39 (3.01%)
- Ex-Dividend Date Nov 23, 2023
- 1y Target Est
13.27
ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, and the Americas. The company operates through Commodities and Life Sciences segments. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides coal sampling, analysis and certification, formation evaluation, and related analytical testing services. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment provides analytical testing data to assist consulting and engineering firms, industries, and governments. ALS Limited was founded in 1863 and is headquartered in Milton, Australia.
www.alsglobal.com19,085
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: ALQ.AX
Performance Overview: ALQ.AX
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALQ.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALQ.AX
Valuation Measures
Market Cap
6.31B
Enterprise Value
7.71B
Trailing P/E
24.30
Forward P/E
18.76
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.75
Price/Book (mrq)
4.44
Enterprise Value/Revenue
3.34
Enterprise Value/EBITDA
13.25
Financial Highlights
Profitability and Income Statement
Profit Margin
11.66%
Return on Assets (ttm)
8.67%
Return on Equity (ttm)
19.50%
Revenue (ttm)
2.38B
Net Income Avi to Common (ttm)
264M
Diluted EPS (ttm)
0.54
Balance Sheet and Cash Flow
Total Cash (mrq)
192M
Total Debt/Equity (mrq)
111.05%
Levered Free Cash Flow (ttm)
264.06M